SEP 29, 2019 2:57 PM PDT

CBD Alleviates Angelman Syndrome Seizures in Mice Trial

WRITTEN BY: Julia Travers

CBD has already been shown to be effective as an anti-anxiety, antipsychotic and anti-epileptic substance. Can it help youth and adults with a rare neurological condition?

Cannabidiol (CBD) can lessen seizure severity in mice that genetically model Angelman syndrome, a rare neurodevelopmental condition. This condition is characterized by brain rhythm dysfunction, intellectual disability, lack of speech and, in many cases, drug-resistant epilepsy. The effectiveness of CBD was tested by University of North Carolina at Chapel Hill (UNC) School of Medicine researchers.

In the lab of Ben Philpot, the team tested the effects of CBD on seizures, brain activity abnormalities and motor deficit in mice that genetically model Angelman syndrome. According to EurekAlert, the Philpot lab creates genetically modified mouse models of neurodevelopmental disorders and uses them to look for new treatments for diseases including Rett, Pitt-Hopkins and Angelman syndromes.

One injection of CBD was found to substantially lessen seizure severity, when the seizures were triggered by loud sound or elevated body temperature. A typical dose of 100 mg/kg of CBD did lead to mild mouse sedation, but it had minimal impact on their balance or coordination. And, CBD reinstituted normal brain rhythms.

"We're confident our study provides the preclinical framework necessary to better guide the rational development of CBD as a therapy to help lessen seizures associated with Angelman syndrome and other neurodevelopmental disorders," Bin Gu, PhD, first author and postdoctoral fellow in the Philpot lab, said.

"There is an unmet need for better treatments for kids with Angelman syndrome to help them live fuller lives and to aid their families and caregivers. Our results show CBD could help the medical community safely meet this need," Ben Philpot, PhD, said.

 

“Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice,” was published in the Journal of Clinical Investigation.

 

Article Source: EurekAlert, Journal of Clinical Investigation

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JUL 17, 2020
Cannabis Sciences
Does Cannabis Really Make Sex Better?
JUL 17, 2020
Does Cannabis Really Make Sex Better?
Cannabis is legal in 39 states. While it is entirely legal in 11 states and the District of Columbia, in another 28, it ...
JUL 30, 2020
Health & Medicine
Navy Goes Overboard on Hemp Ban for Sailors and Marines
JUL 30, 2020
Navy Goes Overboard on Hemp Ban for Sailors and Marines
It may be a federally legal crop, but the Sailors and Marines of the US navy have been told they cannot use hemp in any ...
AUG 14, 2020
Health & Medicine
Does Legalization of Cannabis Mean Users Actually Use Legal Sources?
AUG 14, 2020
Does Legalization of Cannabis Mean Users Actually Use Legal Sources?
Recent research from states that have legalized recreational cannabis, looked at whether users find the drug  is mo ...
AUG 25, 2020
Cannabis Sciences
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
AUG 25, 2020
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
The US Food and Drug Administration has approved Epidiolex, a cannabidiol (CBD) oral solution, to treat seizures linked ...
SEP 25, 2020
Health & Medicine
Does Cannabis Affect Brain Health in Older People?
SEP 25, 2020
Does Cannabis Affect Brain Health in Older People?
Demographic data shows rising cannabis use among older people, so what is the likely effect on cognitive funct ...
NOV 05, 2020
Health & Medicine
Medical Cannabis Reduces Chronic Pain and Opioid Use
NOV 05, 2020
Medical Cannabis Reduces Chronic Pain and Opioid Use
Researchers affiliated with the University of Haifa in Israel have reported on the efficacy of medical cannabis use for ...
Loading Comments...